These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 24317684)
61. Dysregulated gene expression predicts tumor aggressiveness in African-American prostate cancer patients. Ali HEA; Lung PY; Sholl AB; Gad SA; Bustamante JJ; Ali HI; Rhim JS; Deep G; Zhang J; Abd Elmageed ZY Sci Rep; 2018 Nov; 8(1):16335. PubMed ID: 30397274 [TBL] [Abstract][Full Text] [Related]
62. Increased expression of tumor protein D54 is associated with clinical progression and poor prognosis in patients with prostate cancer. Ren L; Chen J; Zhang X Oncol Lett; 2017 Dec; 14(6):7739-7744. PubMed ID: 29250174 [TBL] [Abstract][Full Text] [Related]
63. Prostate Cancer Risk and DNA Methylation Signatures in Aging Rats following Developmental BPA Exposure: A Dose-Response Analysis. Prins GS; Ye SH; Birch L; Zhang X; Cheong A; Lin H; Calderon-Gierszal E; Groen J; Hu WY; Ho SM; van Breemen RB Environ Health Perspect; 2017 Jul; 125(7):077007. PubMed ID: 28728135 [TBL] [Abstract][Full Text] [Related]
64. Tumor Protein D52 (TPD52) Inhibits Growth and Metastasis in Renal Cell Carcinoma Cells Through the PI3K/Akt Signaling Pathway. Zhao Z; Liu H; Hou J; Li T; Du X; Zhao X; Xu W; Xu W; Chang J Oncol Res; 2017 May; 25(5):773-779. PubMed ID: 27983909 [TBL] [Abstract][Full Text] [Related]
65. DNA methylome changes by estradiol benzoate and bisphenol A links early-life environmental exposures to prostate cancer risk. Cheong A; Zhang X; Cheung YY; Tang WY; Chen J; Ye SH; Medvedovic M; Leung YK; Prins GS; Ho SM Epigenetics; 2016 Sep; 11(9):674-689. PubMed ID: 27415467 [TBL] [Abstract][Full Text] [Related]
66. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52. Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891 [TBL] [Abstract][Full Text] [Related]
69. Mapping and Identification of the Urine Proteome of Prostate Cancer Patients by 2D PAGE/MS. Kiprijanovska S; Stavridis S; Stankov O; Komina S; Petrusevska G; Polenakovic M; Davalieva K Int J Proteomics; 2014; 2014():594761. PubMed ID: 25215235 [TBL] [Abstract][Full Text] [Related]
70. Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells. Ummanni R; Teller S; Junker H; Zimmermann U; Venz S; Scharf C; Giebel J; Walther R FEBS J; 2008 Nov; 275(22):5703-13. PubMed ID: 18959755 [TBL] [Abstract][Full Text] [Related]
71. Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer. Byrne JA; Balleine RL; Schoenberg Fejzo M; Mercieca J; Chiew YE; Livnat Y; St Heaps L; Peters GB; Byth K; Karlan BY; Slamon DJ; Harnett P; Defazio A Int J Cancer; 2005 Dec; 117(6):1049-54. PubMed ID: 15986428 [TBL] [Abstract][Full Text] [Related]
72. Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52. Shehata M; Bièche I; Boutros R; Weidenhofer J; Fanayan S; Spalding L; Zeps N; Byth K; Bright RK; Lidereau R; Byrne JA Clin Cancer Res; 2008 Aug; 14(16):5050-60. PubMed ID: 18698023 [TBL] [Abstract][Full Text] [Related]